Ablation of Plasma Prekallikrein Decreases Low-Density Lipoprotein Cholesterol by Stabilizing Low-Density Lipoprotein Receptor and Protects Against Atherosclerosis.
Circulation
; 145(9): 675-687, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-35189703
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prekallikrein
/
Receptors, LDL
/
Atherosclerosis
/
Plaque, Atherosclerotic
/
Cholesterol, LDL
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Circulation
Year:
2022
Document type:
Article
Country of publication:
Estados Unidos